Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Orin Hirschman | IPWR Ideal Power Inc. | 13G | 9.5% | Mar 25, 2024 | 2y |
| Orin Hirschman | IDN Intellicheck, Inc. | 13G | 8.2% | Mar 25, 2024 | 2y |
| Zeng Lingzhi | UCAR U Power Ltd | 13G | 12.19% | Mar 1, 2024 | 2y |
| Xiangmin Cui | CGON CG Oncology, Inc. | 13G/A | 8.2% | Jan 29, 2024 | 2y |
| Oxford Science Enterprises plc | PEPG PepGen Inc. | 13G | 14.7% | May 10, 2022 | 2y |
| Southpoint Capital Advisors LP | TNGX Tango Therapeutics, Inc. | 13G/A | 4.9% | Apr 8, 2024 | 2y |
| GK Investor LLC | GNK Genco Shipping & Trading Ltd | 13D/A | 5.4% | Apr 5, 2024 | 2y |
| Wildcat Capital Management, LLC | ULCC Frontier Group Holdings, Inc. | 13G | 12.6% | Apr 5, 2024 | 2y |
| EquityLine Alternate Assets GP Inc. | MBAI MBody AI Ltd. | 13D/A | 13% | Apr 5, 2024 | 2y |
| John D. Gottwald | TG Tredegar Corp | 13D/A | 20.7% | Apr 4, 2024 | 2y |
| Madryn Asset Management, LP | GBNH Greenbrook TMS Inc. Common Shares | 13D/A | 63.4% | Apr 4, 2024 | 2y |
| Oaktree Capital Holdings, LLC | TRMD TORM plc | 13D/A | 54.86% | Apr 4, 2024 | 2y |
| GREYBROOK HEALTH INC. | GBNH Greenbrook TMS Inc. Common Shares | 13D/A | 54.4% | Apr 4, 2024 | 2y |
| Schlumberger N.V. (Schlumberger Limited) | KITT Nauticus Robotics, Inc. | 13D/A | 17.4% | Apr 4, 2024 | 2y |
| Cloud Alliance Inc | QH QUHUO Ltd | 13D | 25.96% | Apr 4, 2024 | 2y |
| HESTIA CAPITAL PARTNERS LP | PBI Pitney Bowes Inc | 13D/A | 8.9% | Apr 4, 2024 | 2y |
| Schlumberger N.V. (Schlumberger Limited) | KITT Nauticus Robotics, Inc. | 13G | 17.4% | Apr 4, 2024 | 2y |
| EIG Veteran Equity Aggregator, L.P. | USAC USA Compression Partners, LP | 13D/A | 11% | Apr 4, 2024 | 2y |
| OSN Streaming Limited | ANGH Anghami Inc | 13D | 62.9% | Apr 1, 2024 | 2y |
| Albion River Management LLC | DCO Ducommun Inc | 13D | 9% | Apr 1, 2024 | 2y |
| GREAT POINT PARTNERS LLC | OTLK Outlook Therapeutics, Inc. | 13G | 9.99% | Apr 1, 2024 | 2y |
| Nikolay Savchuk | TRAW Traws Pharma, Inc. | 13D | 11.6% | Apr 1, 2024 | 2y |
| ECP ControlCo, LLC | SHEN Shenandoah Telecommunications Co | 13D | 9.95% | Apr 1, 2024 | 2y |
| Philip Fayer | NVEI Nuvei Corporation Subordinate Voting Shares | 13D | 21.8% | Apr 1, 2024 | 2y |
| Spartan Energy Partners LP | KGS Kodiak Gas Services, Inc. | 13D | 6.2% | Apr 1, 2024 | 2y |
| FEDERATED HERMES, INC. | FUSN Fusion Pharmaceuticals Inc. Common Shares | 13G/A | 0.11% | Mar 31, 2024 | 2y |
| Daniel Lau | TSAT Telesat Corp | 13G/A | 6.6% | Mar 28, 2024 | 2y |
| I-B Good Works 4, LLC | IBAC IB Acquisition Corp. | 13D | 18.5% | Mar 28, 2024 | 2y |
| Paradigm Biocapital Advisors LP | YMAB Y-mAbs Therapeutics, Inc. Common Stock | 13G | 5.02% | Mar 27, 2024 | 2y |
| TEACHER RETIREMENT SYSTEM OF TEXAS | AUNA Auna S.A. | 13G | 5.3% | Mar 26, 2024 | 2y |
| EcoR1 Capital, LLC | LENZ LENZ Therapeutics, Inc. | 13G/A | 4.8% | Mar 21, 2024 | 2y |
| Casdin Capital, LLC | IPSC Century Therapeutics, Inc. | 13D/A | 4.95% | Feb 29, 2024 | 2y |
| Yakira Capital Management, Inc. | IRRX Integrated Rail and Resources Acquisition Corp. | 13G/A | 0% | Feb 27, 2024 | 2y |
| Vishal Garg | BETR Better Home & Finance Holding Co | 13D/A | 19.7% | Aug 22, 2023 | 2y |
| MITCHELL SACKS | TACT Transact Technologies Inc | 13G | 5.3% | Apr 5, 2024 | 2y |
| COLUMN GROUP L P | NGM NGM Biopharmaceuticals, Inc. Common Stock | 13D/A | 100% | Apr 5, 2024 | 2y |
| The Sire Group Ltd. | TTNP TITAN PHARMACEUTICAL INC | 13D/A | 14.1% | Apr 5, 2024 | 2y |
| SIT INVESTMENT ASSOCIATES INC | NQP NUVEEN PENNSYLVANIA QUALITY MUNICIPAL INCOME FUND | 13G | 5.41% | Apr 5, 2024 | 2y |
| SIT INVESTMENT ASSOCIATES INC | NBB Nuveen Taxable Municipal Income Fund | 13G | 10.28% | Apr 5, 2024 | 2y |
| SIT INVESTMENT ASSOCIATES INC | NXJ NUVEEN NEW JERSEY QUALITY MUNICIPAL INCOME FUND | 13G | 5.21% | Apr 5, 2024 | 2y |
| SIT INVESTMENT ASSOCIATES INC | NPCT Nuveen Core Plus Impact Fund | 13G | 5.17% | Apr 5, 2024 | 2y |
| Point72 Asset Management, L.P. | STRO Sutro Biopharma, Inc. | 13G | 7.9% | Apr 4, 2024 | 2y |
| James B. Tananbaum | KNTE Kinnate Biopharma Inc. Common Stock | 13D/A | 0% | Apr 3, 2024 | 2y |
| Adage Capital Management, L.P. | ORKA Oruka Therapeutics, Inc. | 13D | 8.28% | Apr 3, 2024 | 2y |
| Chia-Lin Simmons | LGMK LogicMark, Inc. | 13D | 6% | Apr 3, 2024 | 2y |
| Theodore Walker Cheng-De King | OSG Octave Specialty Group Inc | 13G | 6.26% | Apr 2, 2024 | 2y |
| Weilai Zhang | AEHL Antelope Enterprise Holdings Ltd | 13D | 85.77% | Apr 1, 2024 | 2y |
| BlackRock Inc. | TBI TrueBlue, Inc. | 13G/A | 8.4% | Mar 31, 2024 | 2y |
| BlackRock Inc. | CVI Cvr Energy Inc | 13G/A | 4.8% | Mar 31, 2024 | 2y |
| BlackRock Inc. | AAXJ iShares Trust | 13G/A | 0% | Mar 31, 2024 | 2y |